The Rare Disease Project was recently awarded funding by the National Agency for Research and Development (ANID-Chile) for high throughput genotyping equipment, the first in Chile.
For our November G2MC Young Investigator profile, we’re proud to sit down with Nurse and Genetic Counselor, Peter James Abad. Abad is part of the faculty at the University of the Philippines Manila College of Nursing, an affiliate of the Master of Science in Genetic Counseling program at the College of Medicine, and is currently pursuing his Ph.D. in Nursing at the University of Iowa.
Read about G2MC’s latest news, updates, events and more in the August 2022 newsletter.
Read the latest updates on the Genomic Medicine Clinics for Rare Genetic Disorders pilot project.
Read the latest updates from the FHH Flagship Project group.
Family health history is a risk factor for many common chronic diseases, such as cancer and heart disease. Knowing a patient’s family health history can aid in earlier diagnoses of genetic conditions, refine disease risk assessments, inform timing and type of preventive interventions, and motivate behavior change.
The Abu Dhabi Investment Office and Public Policy Projects are coming together to host the webinar ‘Innovation in Genomics in the UK & UAE’ on November 30th
Learn about the G2MC Education Working Group’s latest accomplishments and goals, and how you can contribute to the groups mission.
The Rare and Unknown Disease Project is an interdisciplinary 4-year project, funded by the Chilean Agency for Research and Development (ANID) and is aimed at evaluating the personal, familial, healthcare and societal implications of reaching a diagnosis (or not) via exome sequencing for persons with unknown rare disorders in Chile.
Health IT organization, WEDI, publishes fact sheet on data issues in clinical genomics. The fact sheet was written by WEDI Genomics Work Group co-chair Grant Wood, who is also part of the G2MC leadership team.
We are excited to share that the Global Genomic Medicine Consortium (G2MC) 7th International Conference will be held in 2023 in Geneva, Switzerland. The conference will take place during the September-October timeframe with exact dates to be announced soon. For those unable to attend in person, we will also be incorporating virtual sessions.
Read about G2MC’s latest news, updates, events and more in the August 2022 newsletter.
The Global Alliance for Genomics and Health (GA4GH) is developing a new standard for the representation of pedigree and family health history information.
Drs. Pratiksha Gyawali and Shane Quinonez, members of G2MC’s Family Health History (FHH) group are leading a project to identify the current capacity of providers to deliver medical genetics services in Nepal.
Register here for “Doing better where it counts: Bringing rare disease care to underserved populations” by Science/AAAS G2MC members are invited to join Science/AAAS’s all virtual “Doing better where it counts: Bringing rare disease care to underserved populations.”This Webinar hopes to highlight the following:Obstacles encountered during the diagnostic odyssey for patients with rare diseaseOutline the hardships faced specifically by underserved
Geoffrey Ginsburg, M.D., Ph.D., Founder and Co-Chair of G2MC, will be presented with the 17th Annual Award for Leadership in Personalized Medicine during the Personalized Medicine Coalition (PMC) summit on November 15, 2022.
WHO’s Science Council issued its first report, on accelerating access to genomics for global health.
What To Know About Healthcare Professionals’ Genomics Education Week We all understand the importance of implementing genomics and patient care, but healthcare providers may not be aware of the genomics education resources available. Our partners at the National Human Genome Research Institute, along with several of our colleagues, are organizing a social media campaign from June 6-10 that focuses on
Upcoming Talk: “Genetic and Molecular Determinants Associated with Dropout from and Adherence to Lifestyle Interventions” will be presented by Katherine Collins, PhD, and “AR-pathway-inhibitor resistant prostate cancer: A Systems Biology Approach” will be presented by Nathan Hawkey, MD, on Thursday, May 12, 2022. Registration is required.
G2MC Evidence Working Group Publish Systemic Review New Review published online in Human Genetics as part of the Springer Nature Content Sharing Initiative We are incredibly excited to announce that article “The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review” has been published online in Human Genetics, led and authored by members of the G2MC
